Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
19.42
+0.10 (0.52%)
At close: Nov 13, 2026, 4:00 PM EST
19.47
+0.05 (0.26%)
After-hours: Nov 13, 2026, 7:30 PM EST

Vor Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
78.98396.4981.9531.3657.71119.8
Short-Term Investments
402.5758.729.98105.82172.5487.67
Cash & Short-Term Investments
481.55455.2191.93137.18230.25207.47
Cash Growth
182.50%395.19%-32.99%-40.42%10.98%327.43%
Prepaid Expenses
4.971.154.23.154.374.84
Other Current Assets
4.011.750.380.482.342.09
Total Current Assets
490.52458.1196.51140.8236.95214.4
Property, Plant & Equipment
3.233.4741.5950.157.0822.52
Other Long-Term Assets
2.562.554.87.235.345.67
Total Assets
496.31464.13142.89198.13299.37242.59

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.615.131.510.821.771.55
Accrued Expenses
30.3719.7612.8910.938.086.34
Current Portion of Leases
0.370.284.223.833.271.84
Other Current Liabilities
-----0.43
Total Current Liabilities
36.3425.1718.6115.5713.1210.15
Long-Term Leases
2.442.7227.6231.8335.6416.17
Other Long-Term Liabilities
594.7600.55----
Total Liabilities
633.49628.4446.2347.448.7626.33

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.010.010.010
Additional Paid-In Capital
1,387988.6553.62490.87473.59346.38
Retained Earnings
-1,522-1,153-456.99-340.08-222.22-130.12
Comprehensive Income & Other
-1.850.040.02-0.08-0.77-
Total Common Equity
-137.17-164.3196.66150.72250.61216.26
Shareholders' Equity
-137.17-164.3196.66150.72250.61216.26
Total Liabilities & Equity
496.31464.13142.89198.13299.37242.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2.81331.8335.6638.9118.01
Net Cash (Debt)
478.74452.2160.1101.52191.33189.46
Net Cash Growth
185.98%652.48%-40.80%-46.94%0.99%526.38%
Net Cash Per Share
10.7945.8117.4930.2296.75113.33
Filing Date Shares Outstanding
61.4348.856.243.413.321.87
Total Common Shares Outstanding
61.4338.726.243.393.31.86
Working Capital
454.18432.9377.9125.23223.83204.25
Book Value Per Share
-2.23-4.2415.4944.4075.95116.35
Tangible Book Value
-137.17-164.3196.66150.72250.61216.26
Tangible Book Value Per Share
-2.23-4.2415.4944.4075.95116.35
Machinery
--17.1517.415.648.77
Construction In Progress
--0.040.151.04-
SEC Filings: 10-K · 10-Q